Studies related to Intermediate monocyte proportion and Kefir

Kefir Is A Viable Exercise Recovery Beverage For Cancer Survivors Enrolled In A Structured Exercise Program

Effect None
Trial Design Non-randomized controlled trial
Trial Length 1-6 months
Number of Subjects 24
Sex Both Genders
Age Range 30-44, 45-64, 65+
Notes for this study:
24 cancer survivors, who had undergone chemotherapy and/or radiation at most 2 years previously, did 12 weeks of an exercise regimen (60 minute sessions 3x-week). Half the patients were given kefir to drink after each exercise session, and half were given nothing (control).

Kefir consumption was associated with improvements in lean body mass, depression, fatigue, and gastric distress. The 12 participants who took kefir also saw significant reduction in circulating lipopolysaccharides, increase in proportion of classical monocytes and decrease in proportion of non-classical monocytes.

There was no milk control in this study, so we don't know whether these effects could have been seen with low-fat milk. The kefir in this study was commercial low-fat American kefir, prepared by Lifeway Foods Inc.
Funding issues for this study:
This study was funded by the Research, Dissemination and Faculty Development Program, and the School of Sport and Exercise Science at the University of Northern Colorado. The authors report no competing interests.